BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33194022)

  • 21. RORγt expression in T
    Kluger MA; Nosko A; Ramcke T; Goerke B; Meyer MC; Wegscheid C; Luig M; Tiegs G; Stahl RA; Steinmetz OM
    Clin Exp Immunol; 2017 Apr; 188(1):63-78. PubMed ID: 27880975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression and significance of Th17 and Treg cells in peripheral blood of patients with systemic lupus erythematosus].
    Cai XY; Luo M; Lin XJ; Xu YL; Tang C; Ye JH; Li WN; He ZX; Yu N
    Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(7):460-3. PubMed ID: 22490966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Treg/Th17 imbalance in Toxoplasma gondii-infected pregnant mice.
    Zhang H; Hu X; Liu X; Zhang R; Fu Q; Xu X
    Am J Reprod Immunol; 2012 Feb; 67(2):112-21. PubMed ID: 21923716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chloroquine Autophagic Inhibition Rebalances Th17/Treg-Mediated Immunity and Ameliorates Systemic Lupus Erythematosus.
    An N; Chen Y; Wang C; Yang C; Wu ZH; Xue J; Ye L; Wang S; Liu HF; Pan Q
    Cell Physiol Biochem; 2017; 44(1):412-422. PubMed ID: 29141242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR‑146a‑5p protects against renal injury in MRL/lpr mice via improvement of the Treg/Th17 imbalance by targeting the TRAF6/NF‑κB axis.
    Teng J; Yang F; Li X
    Exp Ther Med; 2023 Jan; 25(1):21. PubMed ID: 38895650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulated fractalkine levels in Chinese patients with lupus nephritis.
    You Y; Qin Y; Lin X; Yang F; Wang J; Yuan F; Sooranna SR; Pinhu L
    Cytokine; 2018 Apr; 104():23-28. PubMed ID: 29414322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The changes of Treg and Th17 cells relate to serum 25(OH)D in patients with initial-onset childhood systemic lupus erythematosus.
    Jiang LJ; Rong ZH; Zhang HF
    Front Pediatr; 2023; 11():1228112. PubMed ID: 37681199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice.
    Inoue A; Hasegawa H; Kohno M; Ito MR; Terada M; Imai T; Yoshie O; Nose M; Fujita S
    Arthritis Rheum; 2005 May; 52(5):1522-33. PubMed ID: 15880599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KN-93, an inhibitor of calcium/calmodulin-dependent protein kinase IV, promotes generation and function of Foxp3⁺ regulatory T cells in MRL/lpr mice.
    Koga T; Mizui M; Yoshida N; Otomo K; Lieberman LA; Crispín JC; Tsokos GC
    Autoimmunity; 2014 Nov; 47(7):445-50. PubMed ID: 24829059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of nonmyeloablative unrelated fetal and neonatal murine peripheral blood mononuclear cell infusion on MRL/lpr mice.
    Chuan W; Wu-qing W; Zhu-wen Y; Zuo L
    Lupus; 2014 Sep; 23(10):994-1005. PubMed ID: 24756437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased CD4
    Ma YH; Zhang J; Chen X; Xie YF; Pang YH; Liu XJ
    World J Gastroenterol; 2016 Nov; 22(42):9356-9367. PubMed ID: 27895423
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Kim DS; Park Y; Choi JW; Park SH; Cho ML; Kwok SK
    Front Immunol; 2021; 12():696074. PubMed ID: 34956169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylprednisolone attenuates lipopolysaccharide-induced Fractalkine expression in kidney of Lupus-prone MRL/lpr mice through the NF-kappaB pathway.
    You Y; Qin Y; Lin X; Yang F; Li J; Sooranna SR; Pinhu L
    BMC Nephrol; 2015 Aug; 16():148. PubMed ID: 26310926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
    J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CXCL13 blockade attenuates lupus nephritis of MRL/lpr mice.
    Wu X; Guo J; Ding R; Lv B; Bi L
    Acta Histochem; 2015 Oct; 117(8):732-7. PubMed ID: 26456520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FKN secreted by kidney epithelial cells regulates macrophage activation in lupus nephritis
    Zuo Y; Pan X; Wang X; You Y
    Lupus; 2023 Oct; 32(12):1381-1393. PubMed ID: 37751892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulated IL-17A secretion and CCR6 co-expression in Treg subsets are related to the imbalance of Treg/Th17 cells in active UC patients.
    Long Y; Zhao X; Xia C; Li X; Fan C; Liu C; Wang C
    Scand J Immunol; 2020 Jun; 91(6):e12842. PubMed ID: 31660620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exacerbation of lupus nephritis by high sodium chloride related to activation of SGK1 pathway.
    Yang X; Yao G; Chen W; Tang X; Feng X; Sun L
    Int Immunopharmacol; 2015 Dec; 29(2):568-573. PubMed ID: 26474695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
    J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells.
    Yao L; Chen HP; Ma Q
    Immunol Lett; 2014 Sep; 161(1):76-80. PubMed ID: 24837470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.